These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 23663365
1. Synthesis, anti-MRSA, and anti-VRE activity of hemin conjugates with amino acids and branched peptides. Okorochenkov SA, Zheltukhina GA, Mirchink EP, Isakova EB, Feofanov AV, Nebolsin VE. Chem Biol Drug Des; 2013 Oct; 82(4):410-7. PubMed ID: 23663365 [Abstract] [Full Text] [Related]
5. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Namba K, Zheng X, Motoshima K, Kobayashi H, Tai A, Takahashi E, Sasaki K, Okamoto K, Kakuta H. Bioorg Med Chem; 2008 Jun 01; 16(11):6131-44. PubMed ID: 18468909 [Abstract] [Full Text] [Related]
7. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Wang Z, Cao B, Liu YM, Gu L, Wang C. Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138 [Abstract] [Full Text] [Related]
8. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds. Yamamoto Y, Kurazono M. Bioorg Med Chem Lett; 2007 Mar 15; 17(6):1626-8. PubMed ID: 17254785 [Abstract] [Full Text] [Related]
9. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents. Hu L, Kully ML, Boykin DW, Abood N. Bioorg Med Chem Lett; 2009 Jul 01; 19(13):3374-7. PubMed ID: 19481935 [Abstract] [Full Text] [Related]
10. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities. Kobayashi Y, Ichioka M, Hirose T, Nagai K, Matsumoto A, Matsui H, Hanaki H, Masuma R, Takahashi Y, Omura S, Sunazuka T. Bioorg Med Chem Lett; 2010 Oct 15; 20(20):6116-20. PubMed ID: 20833545 [Abstract] [Full Text] [Related]
11. Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents. Hu L, Kully ML, Boykin DW, Abood N. Bioorg Med Chem Lett; 2009 Mar 01; 19(5):1292-5. PubMed ID: 19208475 [Abstract] [Full Text] [Related]
12. Identification of a novel protein synthesis inhibitor active against gram-positive bacteria. Eibergen NR, Im I, Patel NY, Hergenrother PJ. Chembiochem; 2012 Mar 05; 13(4):574-83, 490. PubMed ID: 22362659 [Abstract] [Full Text] [Related]
13. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections]. Li JT, Li Y, Wang J, China Bacterial Resistance Surveillance Study Group. Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):365-74. PubMed ID: 12820911 [Abstract] [Full Text] [Related]
14. Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK). Martínez-Botella G, Breen JN, Duffy JE, Dumas J, Geng B, Gowers IK, Green OM, Guler S, Hentemann MF, Hernandez-Juan FA, Joseph-McCarthy D, Kawatkar S, Larsen NA, Lazari O, Loch JT, Macritchie JA, McKenzie AR, Newman JV, Olivier NB, Otterson LG, Owens AP, Read J, Sheppard DW, Keating TA. J Med Chem; 2012 Nov 26; 55(22):10010-21. PubMed ID: 23043329 [Abstract] [Full Text] [Related]
15. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Sader HS, Moet GJ, Farrell DJ, Jones RN. Diagn Microbiol Infect Dis; 2011 Jul 26; 70(3):412-6. PubMed ID: 21546202 [Abstract] [Full Text] [Related]
16. Isoplatensimycin: Synthesis and biological evaluation. Jang KP, Kim CH, Na SW, Kim H, Kang H, Lee E. Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4601-2. PubMed ID: 19604693 [Abstract] [Full Text] [Related]
18. Synthesis and evaluation of isatin-β-thiosemicarbazones as novel agents against antibiotic-resistant Gram-positive bacterial species. Zhang XM, Guo H, Li ZS, Song FH, Wang WM, Dai HQ, Zhang LX, Wang JG. Eur J Med Chem; 2015 Aug 28; 101():419-30. PubMed ID: 26185006 [Abstract] [Full Text] [Related]
19. Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]-Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE. Silverman SM, Moses JE, Sharpless KB. Chemistry; 2017 Jan 01; 23(1):79-83. PubMed ID: 27747932 [Abstract] [Full Text] [Related]
20. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains]. Efe S, Sinirtaş M, Ozakin C. Mikrobiyol Bul; 2009 Oct 01; 43(4):639-43. PubMed ID: 20084917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]